McHenry T. Tichenor, Jr. (also known as Mac Tichenor) serves as the Director and Managing Partner of Tichenor Ventures. See sector focus and contact routes.
McHenry T. Tichenor, Jr. (also known as Mac Tichenor) serves as the Director and Managing Partner of Tichenor Ventures, a private investment company he founded in 2010 that concentrates on early-stage life sciences and biotechnology. His investment thesis focuses exclusively on early-stage biotech companies within the healthcare sector, primarily in the United States, driven by his personal mission to find less toxic cancer treatments after losing his son to the disease. While specific check sizes and lead/follow behavior are not publicly documented, the firm’s latest known activity was a Series A investment in OS Therapies in April 2021. Notable portfolio companies include OS Therapies and Dose Therapeutics, where Tichenor serves as a Director. Tichenor’s distinctive point of view is deeply personal: he invests to advance sarcoma and osteosarcoma research, and he concurrently leads the QuadW Foundation and the Osteosarcoma Institute to support these causes. He holds an M.S. in biotechnology from The University of Texas at Dallas and previously led Tichenor Media System, which merged into Univision Communications.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Dallas.
Investors like McHenry T. Tichenor, Jr. · Full investor directory · Investor access · Company funding database